Paul_Moraviec

Paul Moraviec

Paul Moraviec

British businessman

Not to be confused with Paul Moravec.

Paul Moraviec (born April 1958)[1] is a British businessman. He was the chief executive officer (CEO) of Convatec, an international medical products and technologies company, listed on the FTSE 100 Index, from April 2015 to October 2018.[2]

Quick Facts Born, Nationality ...

Early life

Moraviec has a master's degree in marketing from London's Kingston University Business School.[3]

Career

Before joining Convatec, he was vice president, neurosurgery business at Johnson & Johnson, and vice president, international commercialoperations at Abbott Laboratories.[4]

Convatec announced that Moraviec will be retiring with immediate effect on 15 October 2018, and will be succeeded on an interim basis by non-executive director Rick Anderson, who was formerly the chairman of Johnson & Johnson.[5]

References

  1. [1]
    "Paul MORAVIEC - Personal Appointments (free information from Companies House)". Beta.companieshouse.gov.uk. Retrieved 18 December 2016.
  2. [2]
    "ConvaTec Appoints Paul Moraviec CEO Effective April 30, 2015". Convatec.co.uk. 30 April 2015. Retrieved 18 December 2016.
  3. [3]
    Paul Moraviec (22 December 2014). "Paul Moraviec: Executive Profile & Biography". Bloomberg. Retrieved 18 December 2016.
  4. [4]
    "Paul Moraviec". The Wall Street Journal.
  5. [5]
    "Paul Moraviec". Convatec.


Stub icon

This United Kingdom business-related biographical article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Paul_Moraviec, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.